Pre-earnings options volume in Sana Biotechnology (SANA) is normal with calls leading puts 27:1. Implied volatility suggests the market is anticipating a move near 17.5%, or 73c, after results are released. Median move over the past eight quarters is 4.0%.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SANA:
- Sana Biotechnology price target raised to $8 from $5 at Citizens JMP
- Sana Biotechnology Advances CAR-T Therapy with SC262 in Non-Hodgkin’s Lymphoma Study
- Sana Biotechnology’s SC291 Study: A Promising Step in Autoimmune Disease Treatment
- Sana Biotechnology strength attributed to EMJ Capital long call
- Wedbush bullish on Sana Biotechnology, initiates with an Outperform